{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Identification of drugs with potential anti-coronavirus effects\",\"Impact\":\"Uncontrolled use or promotion of drugs without sufficient testing or clinical trials\",\"Mitigation\":\"Conducting rigorous testing and clinical trials to confirm the safety and efficacy of identified drugs\",\"Technologies\":\"Clinical trial protocols, laboratory testing and analysis tools\",\"People\":\"Patients, healthcare providers, regulatory agencies\",\"Owner\":\"Healthcare providers, pharmaceutical companies, regulatory agencies\"},{\"Description\":\"Use of ontology-based integration and analysis of anti-coronavirus drugs\",\"Impact\":\"Misinterpretation of data leading to inappropriate drug use or treatment\",\"Mitigation\":\"Validation of data and results by domain experts and researchers, clear communication of findings\",\"Technologies\":\"Semantic similarity calculation methods, ontology mapping tools, data validation techniques\",\"People\":\"Researchers, healthcare providers, policy makers\",\"Owner\":\"Researchers, healthcare providers, policy makers\"},{\"Description\":\"Unregulated promotion of drugs based on information extracted from ontologies\",\"Impact\":\"Potential risk of adverse effects or drug interactions due to uninformed or inappropriate use\",\"Mitigation\":\"Education and guidance on proper drug usage, monitoring of adverse effects, regulatory oversight\",\"Technologies\":\"Drug information databases, adverse event monitoring systems, patient education tools\",\"People\":\"Patients, healthcare providers, pharmaceutical companies\",\"Owner\":\"Healthcare providers, regulatory agencies\"}]}"}}